Thymic carcinoma other imaging findings

Thymic Carcinoma Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thymic carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Thymic carcinoma other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Thymic carcinoma other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thymic carcinoma other imaging findings
CDC on Thymic carcinoma other imaging findings
Thymic carcinoma other imaging findings in the news
Blogs on Thymic carcinoma other imaging findings
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Thymic carcinoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]Parminder Dhingra, M.D. [3]

Overview

Other imaging studies for thymic carcinoma include FDG PET scan. The standarized uptake value (SUV) in the FDG PET is much higher for the thymic carcinoma than thymoma, with a high sensitivity (84.6%) and specificity (92.3%).

Other Imaging Findings

FDG PET

FDG (Fludeoxyglucose) PET is a useful image study that allows differentiation between a thymoma and thymic carcinoma. The standarized uptake value (SUV) in the FDG PET is much higher for the thymic carcinoma, with a high sensitivity (84.6%) and specificity (92.3%).